首页 | 本学科首页   官方微博 | 高级检索  
     


Interleukin-18 promoter polymorphisms and the disease progression of Hepatitis B virus-related liver disease
Authors:Kiyoshi Migita  Kazumi Sawakami-Kobayashi  Yumi Maeda  Kazuhiko Nakao  Susumu Kondoh  Mika Sugiura  Ryoko Kawasumi  Osamu Segawa  Hideji Tajima  Masayuki Machida  Minoru Nakamura  Koji Yano  Seigo Abiru  Eiji Kawasaki  Hiroshi Yatsuhashi  Katsumi Eguchi  Hiromi Ishibashi
Affiliation:1. Department of Orthopaedics, Xuhui Central Hospital, Shanghai, China;2. Department of Joint Center, Changzheng Hospital, the Second Military Medical University, Shanghai, China;2. Department of Medicine (DIMED), Surgical Pathology and Cytopathology Unit, University of Padua, Padua, Italy;3. Department of Surgical Oncology and Gastroenterological Sciences, General Oncology Unit, University of Padua, Padua, Italy;4. Istituto Oncologico del Veneto (IOV), IRCCS, Padua, Italy;5. Department of Surgical Oncology and Gastroenterological Sciences, Surgery Unit, University of Padua, Padua, Italy;1. Department of Urology & Oncological Science, Icahn School of Medicine at Mount Sinai, New York, NY;2. Department of Urologic Oncology, Fox Chase Cancer Center-Temple Health System, Philadelphia, PA;3. Division of Biostatistics, Fox Chase Cancer Center-Temple Health System, Philadelphia, PA;4. Division of Pathology, Fox Chase Cancer Center-Temple Health System, Philadelphia, PA;1. National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, Australia;2. Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia;3. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland;4. Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia;5. Faculty of Medicine, Erasmus University, Rotterdam, The Netherlands;6. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;7. Department of Medicine, Mount Sinai School of Medicine, NY, USA;8. Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Australia;9. School of Medicine, The University of Norte Dame, Sydney, Australia;10. Department of Medical Oncology, The Canberra Hospital, Canberra, Australia;11. ANU Medical School, Australian National University, Canberra, Australia;12. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland;13. Prince of Wales Clinical School, University of New South Wales, Sydney, Australia;1. Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Avenida de Bellavista S/N, 41014 Seville, Spain;2. Department of Infectious Diseases, Hospital Carlos III, Calle Sinesio Delgado 10, 28029 Madrid, Spain;3. Unit of Infectious Diseases, Maimónides Institute for Biomedical Research (IMIBIC), Hospital Universitario Reina Sofía, Avd. Menéndez Pidal S/N, 14004 Cordoba, Spain;4. Immunogenetics Unit, Faculty of Sciences, Universidad de Jaén, Campus Las Lagunillas S/N, 23071 Jaen, Spain;1. Division of Pediatric Gastroenterology, Bnai Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel;2. Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel;3. Division of Gastroenterology, Bnai Zion Medical Center, Faculty of Medicine, Technion, Haifa, Israel
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号